Chiral

Chiral is accelerating computational discovery with its AI-powered SaaS platform. The company aims to make complex computational research faster, easier, and more affordable. Their platform transforms computational research across diverse fields such as Pharma, Biotech, Cosmetics, and Academia, by offering AI-powered workflows and automated analysis. For Pharma, it accelerates drug discovery and molecular simulation. In Biotech, it supercharges wet lab experiments with computational ones. For Cosmetics, it aids in discovering safer formulations without animal testing. Academically, it empowers researchers with highly reproducible workflows. Chiral's proprietary platform technology enables no-code workflows powered by AI, cutting research time in half. It features AI-enhanced analysis using advanced machine learning algorithms to identify patterns and generate actionable insights from molecular data. The scalable, cloud-native architecture supports projects from individual research to enterprise-wide computational biology initiatives. This leads to up to 10x faster iteration, lower compute and operational costs, and better, AI-curated decisions, alongside automated data management for enhanced reproducibility.